Status:
UNKNOWN
EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy
Lead Sponsor:
The University of Hong Kong
Conditions:
Cancer of Pancreas
Pancreatic Neoplasms
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Many cancer patients suffer from intractable pain and which is often suboptimally controlled by even strong opioid analgesics. Coeliac plexus neurolysis (CPN) is procedure which intended to permanentl...
Detailed Description
The aim of this study is to compare the efficacy of EUS-guided CPN versus radiofrequency ablation in patients with pain related to pancreatic cancer. By performing a randomized controlled trial, the c...
Eligibility Criteria
Inclusion
- Age ≥18 year-old
- Patients who give informed consent to the study
- Suboptimal pain control with regular analgesics
- Inoperable cancer of pancreas
Exclusion
- Patients who refuse to give consent
- Patients aged \<18 years
- EUS not possible due to:
- Problem related to scope insertion such as trismus, stenosis of the upper GI tract Coagulopathy with INR \>1.5 or platelet count \< 70
- Low oxygen saturation or extreme blood pressure render endoscopic procedure unsafe
Key Trial Info
Start Date :
September 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2024
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04809935
Start Date
September 21 2020
End Date
January 31 2024
Last Update
March 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong, 000000